Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: Studies of phenytoin para-hydroxylation

被引：0
作者：
Schmider, J [1 ]
Greenblatt, DJ [1 ]
vonMoltke, LL [1 ]
Karsov, D [1 ]
Shader, RI [1 ]
机构：
[1] TUFTS UNIV,SCH MED,BOSTON,MA 02111
来源：
PSYCHOPHARMACOLOGY BULLETIN | 1996年 / 32卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：511 / 511
页数：1
相关论文
共 50 条
  • [31] Severe phenytoin intoxication in a subject homozygous for CYP2C9*3
    Brandolese, R
    Scordo, MG
    Spina, E
    Gusella, M
    Padrini, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (04) : 391 - 394
  • [32] Phenytoin toxicity in a Korean patient homozygous for CYP2C9*3
    Lee, Soo-Youn
    Kim, Jong-Won
    Kim, Jong-Soo
    MOLECULAR & CELLULAR TOXICOLOGY, 2006, 2 (04) : 262 - 265
  • [33] Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
    Thakkar, Akanksha N.
    Bendkhale, Shital R.
    Taur, Santosh R.
    Gogtay, Nithya J.
    Thatte, Urmila M.
    NEUROLOGY INDIA, 2012, 60 (06) : 577 - 580
  • [34] Phenytoin Toxicity in Elderly Patient in the Presence of CYP2C9 Mutation
    Bharath, Suman
    Silveira, Diosely
    NEUROLOGY, 2020, 94 (15)
  • [35] Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors
    Nelson, MH
    Birnbaum, AK
    Remmel, RP
    EPILEPSY RESEARCH, 2001, 44 (01) : 71 - 82
  • [36] In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin
    Desta, Z
    Soukhova, N
    Flockhart, DA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (02) : 162 - 168
  • [37] Mechanism of CYP2C9 Inhibition by Flavones and Flavonols
    Si, Dayong
    Wang, Ying
    Zhou, Yi-Han
    Guo, Yingjie
    Wang, Juan
    Zhou, Hui
    Li, Ze-Sheng
    Fawcett, J. Paul
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) : 629 - 634
  • [38] An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects
    Chang, Wan-Chun
    Hung, Shuen-Iu
    Carleton, Bruce C.
    Chung, Wen-Hung
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (08) : 723 - 734
  • [39] Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes
    Lewis, David F. V.
    Lake, Brian G.
    Ito, Yuko
    Dickins, Maurice
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2006, 21 (04) : 385 - 389
  • [40] Phenotypic evaluation of CYP2C9 by way of phenytoin metabolic ratio (PMR).
    Adar, L
    Bialer, M
    Muszkat, M
    Caraco, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P60 - P60
12345